Healthium acquires AbGel to strengthen portfolio in surgical care

Healthium has acquired AbGel gelatin sponge business from Mumbaibased Shri SGK Labs, adding to its product portfolio focused on surgical and post-surgical care. Earlier this financial year, the company had acquired VitalCare Group in the UK to grow its urology portfolio and expand its market in Europe and the US. Bengaluru-based Healthium aims to further expand the market access of this portfolio using its wide network of hospitals across India. AbGel is an absorbable gelatin sponge, manufactured from highly purified neutral gelatin with haemostatic capabilities and is designed to control blood oozing in instances of haemorrhage from multiple small vessels, and is completely absorbed in four to five weeks with no residue or encapsulation. It is non-toxic, non-allergic, non-immunogenic and non-pyrogenic. AbGel is beneficial in effectively managing this across a wide variety of specialities including abdominal surgery, neurosurgery, gynaecological surgery, ENT surgery, dental surgery and oncosurgery.